Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6420
    -0.0006 (-0.09%)
     
  • OIL

    83.68
    +0.95 (+1.15%)
     
  • GOLD

    2,402.80
    +4.80 (+0.20%)
     
  • Bitcoin AUD

    100,460.28
    +5,280.63 (+5.55%)
     
  • CMC Crypto 200

    1,326.41
    +13.78 (+1.05%)
     
  • AUD/EUR

    0.6026
    -0.0005 (-0.09%)
     
  • AUD/NZD

    1.0891
    +0.0016 (+0.15%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,836.67
    -40.38 (-0.51%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,656.62
    -180.78 (-1.01%)
     
  • Hang Seng

    16,239.58
    -146.29 (-0.89%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Why MacroGenics Stock Is Skyrocketing Today

Shares of MacroGenics (NASDAQ: MGNX) were skyrocketing 27.8% higher as of 12:47 p.m. ET on Tuesday. A filing to the U.S. Securities and Exchange Commission on June 17 revealed that MacroGenics CFO James Karrels recently bought 40,000 shares. It's not unusual for clinical-stage biotech stocks to jump when key insiders buy shares.